-
Hyderabad: Researchers from the University of Hyderabad (UoH) along with other researchers have developed artificial intelligence-based models to predict the risk of the rare but life-threatening fungal infection, Mucormycosis, among Covid-19 patients at the time of discharge from the hospital. The collaborative study included a dataset of 1,229 Covid-19 positive patients and 214 inpatients, Covid-19 […]
-
Hyderabad: Three successive waves of Covid pandemic in the last two years, led to unique public health challenges for general public, private and government hospitals in Telangana. This was for the first time that State governments across the country had to face such unique healthcare difficulties during a pandemic that impacted a large cross section […]
-
Hyderabad: Specialists at LBR Dental and Implant Center, Madhapur performed a complex maxillofacial surgery to restore the upper jaw of a 55-year-old-patient from Karimnagar. The patient had lost the jaw due to Mucormycosis after recovering from Covid and the hospital implant surgeons employed advanced dental implants including BioLine Zygomatic and Tubero Pterygoid to restore the […]
-
Hyderabad: Dental and maxillofacial surgeons at Medicover Hospitals, Madhapur, have successfully reconstructed the entire jaw bone of two patients who had lost their ability to speak due to black fungus or Mucormycosis after testing positive for Covid-19. Both the patients had recovered from Covid-19 but later realised that they lost their ability to speak, chew […]
-
The State government had converted Gandhi Hospital into a Covid-only facility in April. As a result, services for all non-Covid general patients had to be stopped at the hospital.
-
The disease is being detected among patients who are recovering or have recovered from COVID-19.
-
"The intensity of the third wave will depend on how people take precautions such as masking, physical distancing and avoiding mass gatherings,” Dr M Raja Rao
-
Of the total cases reported, only 1,418 were now active after 1,635 patients had recovered.
-
Given the sudden surge in the demand for Amphotericin-B which is being prescribed for patients suffering from mucormycosis, the Union government while remaining engaged with the drug manufacturers has decided to make allocation
-
DV Sadananda Gowda said that a total of 53,000 vials of Conventional Amphotericin B have also been allocated to all the states, UTs and Central Institutions today.
-
HC bench said it wanted to ascertain whether the Union government was ensuring an "equitable distribution" of drugs based on the number of active cases of Mucormycosis in each state
-
Dose of lyophilised Amphotericin needs to be titrated against GFR/renal functions and Amphotericin-B (crystalline) should be preferred
-
Policyholders must adhere to the terms and conditions of their health insurance policy including notifying the insurers of pre-existing illnesses, planned or emergency hospitalisations.
-
Finance Minister Harish Rao said that the hospital have procured a high end endoscopy monitor besides getting the drugs such as Amphotericin B Vials
-
Hyderabad firm develops an alternative emulsion-based formulation in three weeks, to overcome the short supply of Liposomal Amphotericin B
-
According to authorities, till May 27, there were 744 patients undergoing treatment at government and private hospitals across State
-
A fake claim about the formation of fungus in refrigerators and the fungus seen on the outer layers of onions causing mucormycosis is doing the rounds on social media
-
Union Minister for Chemicals and Fertilizers D.V Sadananda Gowda announced that the additional 29,250 vials of Amphotericin-B were allocated to all states and the UTs
-
The fresh allocation of the anti-fungal drug is in addition to the 890 vials that were released by the Centre on Friday.
-
The central government has made it mandatory for states to report both suspected and confirmed cases of mucormycosis to the Integrated Disease Surveillance Programme (IDSP).